Evidence map›Paper›PMID 26124242›Full record

ArticleJournal of bacteriology2015

From (p)ppGpp to (pp)pGpp: Characterization of Regulatory Effects of pGpp Synthesized by the Small Alarmone Synthetase of Enterococcus faecalis.

Anthony O Gaca, Pavel Kudrin, Cristina Colomer-Winter, Jelena Beljantseva, Kuanqing Liu, Brent Anderson, Jue D Wang, Dominik Rejman, Katarzyna Potrykus, Michael Cashel and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bacteriology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 98 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. The extended (p)ppGpp family: New dimensions in Stress response.Current research in microbial sciences · 2021
    Review
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 5 countries.

Anthony O GacaCenter for Oral Biology and Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA.
Pavel KudrinUniversity of Tartu, Institute of Technology, Tartu, Estonia.
Cristina Colomer-WinterCenter for Oral Biology and Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA.
Jelena BeljantsevaUniversity of Tartu, Institute of Technology, Tartu, Estonia.
Kuanqing LiuDepartment of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Brent AndersonDepartment of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Jue D WangDepartment of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Dominik RejmanInstitute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic v.v.i., Prague, Czech Republic.
Katarzyna PotrykusDepartment of Molecular Biology, University of Gdańsk, Gdańsk, Poland Section on Molecular Regulation, Program in Genomics of Development, Eunice Kennedy Shriver NICHD, NIH, Bethesda, Maryland, USA.
Michael CashelSection on Molecular Regulation, Program in Genomics of Development, Eunice Kennedy Shriver NICHD, NIH, Bethesda, Maryland, USA.
Vasili HauryliukUniversity of Tartu, Institute of Technology, Tartu, Estonia Department of Molecular Biology and Laboratory for Molecular Infection Medicine Sweden, Umeå University, University Hospital Area, Umeå, Sweden vasili.hauryliuk@umu.se jose_lemos@urmc.rochester.edu.
José A LemosCenter for Oral Biology and Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA vasili.hauryliuk@umu.se jose_lemos@urmc.rochester.edu.
University of Rochester Medical Center · USUniversity of Wisconsin–Madison · USEunice Kennedy Shriver National Institute of Child Health and Human Development · USUniversity of Tartu · EECzech Academy of Sciences, Institute of Organic Chemistry and Biochemistry · CZUmeå University · SE

Funding

GRADUATE TRAINING IN MOLECULAR BIOSCIENCEST32GM007215 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI HULL, CHRISTINA M · 1985 to 2018
$22.5M
Integration Of Macromolecular SynthesisZIAHD000067 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI CASHEL, MICHAEL · 2009 to 2021
$6.1M
Training Program in Oral ScienceT90DE021985 · NIDCR · UNIVERSITY OF ROCHESTER · PI OVITT, CATHERINE, YULE, DAVID I · 2011 to 2021
$5.6M
Control of GTP Homeostasis by (p)ppGppR01GM084003 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI WANG, JUE D. · 2009 to 2017
$2.2M
NIDCR NIH HHS T90 DE021985NIGMS NIH HHS R01 GM084003NIGMS NIH HHS R01GM084003NIGMS NIH HHS T32 GM007215
6 · The paper itself

Abstract

unlabelledThe bacterial stringent response (SR) is a conserved stress tolerance mechanism that orchestrates physiological alterations to enhance cell survival. This response is mediated by the intracellular accumulation of the alarmones pppGpp and ppGpp, collectively called (p)ppGpp. In Enterococcus faecalis, (p)ppGpp metabolism is carried out by the bifunctional synthetase/hydrolase E. faecalis Rel (RelEf) and the small alarmone synthetase (SAS) RelQEf. Although Rel is the main enzyme responsible for SR activation in Firmicutes, there is emerging evidence that SASs can make important contributions to bacterial homeostasis. Here, we showed that RelQEf synthesizes ppGpp more efficiently than pppGpp without the need for ribosomes, tRNA, or mRNA. In addition to (p)ppGpp synthesis from GDP and GTP, RelQEf also efficiently utilized GMP to form GMP 3'-diphosphate (pGpp). Based on this observation, we sought to determine if pGpp exerts regulatory effects on cellular processes affected by (p)ppGpp. We found that pGpp, like (p)ppGpp, strongly inhibits the activity of E. faecalis enzymes involved in GTP biosynthesis and, to a lesser extent, transcription of rrnB by Escherichia coli RNA polymerase. Activation of E. coli RelA synthetase activity was observed in the presence of both pGpp and ppGpp, while RelQEf was activated only by ppGpp. Furthermore, enzymatic activity of RelQEf is insensitive to relacin, a (p)ppGpp analog developed as an inhibitor of "long" RelA/SpoT homolog (RSH) enzymes. We conclude that pGpp can likely function as a bacterial alarmone with target-specific regulatory effects that are similar to what has been observed for (p)ppGpp. IMPORTANCE: Accumulation of the nucleotide second messengers (p)ppGpp in bacteria is an important signal regulating genetic and physiological networks contributing to stress tolerance, antibiotic persistence, and virulence. Understanding the function and regulation of the enzymes involved in (p)ppGpp turnover is therefore critical for designing strategies to eliminate the protective effects of this molecule. While characterizing the (p)ppGpp synthetase RelQ of Enterococcus faecalis (RelQEf), we found that, in addition to (p)ppGpp, RelQEf is an efficient producer of pGpp (GMP 3'-diphosphate). In vitro analysis revealed that pGpp exerts complex, target-specific effects on processes known to be modulated by (p)ppGpp. These findings provide a new regulatory feature of RelQEf and suggest that pGpp may represent a new member of the (pp)pGpp family of alarmones.

Indexed as

Bacterial ProteinsDeoxyguanosineDipeptidesEnterococcus faecalisGene Expression Regulation, BacterialGene Expression Regulation, EnzymologicGuanosine DiphosphateGuanosine PentaphosphateGuanosine TetraphosphateGuanosine TriphosphateLigasesMagnesiumMolecular StructureStress, PhysiologicalSubstrate SpecificityBacterial ProteinsDeoxyguanosineDipeptidesGuanosine DiphosphateGuanosine PentaphosphateGuanosine TetraphosphateGuanosine TriphosphateLigasesMagnesiumrelacin

Identifiers

PMID26124242
PMCPMC4542164
OpenAlexW2105526082

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.